Related Experiment Video
Updated: Jan 11, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Prognostic value of combining nutritional inflammatory index trajectories and tumor characteristics in cervical
Wen Xing1, Zhongjie Wang1, Yan Zhu1
1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Objective:
This investigation seeks to examine how varying longitudinal patterns in nutritional inflammatory index (NII) correlate with clinical outcomes in cervical cancer patients, while developing predictive models for prognosis.
Methods:
We retrospectively analyzed 502 surgically treated cervical cancer cases, incorporating comprehensive clinical parameters, laboratory measurements, and longitudinal follow-up data. Three NII components-advanced lung cancer inflammation index (ALI), neutrophil-albumin ratio (NAR), and prognostic nutritional index (PNI)-were evaluated for their temporal dynamics and relationships with overall survival (OS) and progression-free survival (PFS). Machine learning techniques identified critical predictors for constructing nomograms estimating 3-, 5-, and 10-year survival probabilities.
Results:
Patients maintaining consistently low ALI/PNI values or elevated NAR levels demonstrated significantly poorer outcomes, manifesting earlier disease progression or mortality (log-rank p < 0.001). Based on the key variables screened by the machine learning algorithm, the OS model integrates variables such as NII (PNI), tumor characteristics (federation of gynecology and obstetrics (FIGO) grade, tumor size, lymph node metastasis, cancer antigen 125 (CA125), squamous cell carcinoma (SCC_Ag)), and surgical intervention, while the PFS model incorporates multi-dimensional factors such as PNI, FIGO stage, tumor size, lymph node metastasis, diabetes, surgery, and targeted therapy. Predictive accuracy remained robust across timepoints, with OS model AUCs of 0.894 (95%CI:0.853-0.934), 0.917 (0.88-0.954), and 0.925 (0.883-0.967) for 3-, 5-, and 10-year predictions respectively. Corresponding PFS model AUCs were 0.903 (0.868-0.938), 0.902 (0.865-0.939), and 0.905 (0.862-0.948).
Conclusion:
This study identifies that sustained low ALI/PNI or elevated NAR levels are strongly associated with adverse clinical outcomes in cervical cancer, including earlier progression and mortality.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis